$DMII
Drugs Made In America Acquisition II Corp.
CIK:0002040475|SEC Filings
Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||||
| Operating expenses | ||||||||
| General and administrative costs | $ 112,227 | $ 38,073 | $ 244,257 | $ 97,400 | ||||
| Total operating expenses | 112,227 | 38,073 | 244,257 | 97,400 | ||||
| Loss from operations | (112,227) | (38,073) | (244,257) | (97,400) | ||||
| Other income | ||||||||
| Interest earned on cash and investments held in Trust Account | 4,508,683 | 8,948,533 | ||||||
| Recovery of credit losses | 30,000 | |||||||
| Total other income | 4,508,683 | 8,978,533 | ||||||
| Net income (loss) | $ 4,396,456 | $ (38,073) | $ 8,734,276 | $ (97,400) | ||||
| Redeemable Ordinary Shares | ||||||||
| Other income | ||||||||
| Weighted average ordinary shares outstanding, Basic | 50,000,000 | 50,000,000 | ||||||
| Weighted average ordinary shares outstanding, Diluted | 50,000,000 | 50,000,000 | ||||||
| Basic net income (loss) per ordinary share | $ 0.07 | $ 0.14 | ||||||
| Diluted net income (loss) per ordinary share | $ 0.07 | $ 0.14 | ||||||
| Non-Redeemable Ordinary Shares | ||||||||
| Other income | ||||||||
| Weighted average ordinary shares outstanding, Basic | [1],[2] | 13,700,000 | 12,500,000 | 13,700,000 | 12,500,000 | |||
| Weighted average ordinary shares outstanding, Diluted | [1],[2] | 13,700,000 | 12,500,000 | 13,700,000 | 12,500,000 | |||
| Basic net income (loss) per ordinary share | $ 0.07 | $ (0) | $ 0.14 | $ (0.01) | ||||
| Diluted net income (loss) per ordinary share | $ 0.07 | $ (0) | $ 0.14 | $ (0.01) | ||||
| ||||||||